Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 12, 2015, Pages 1991-2002

  Scholz, Juliane ^a   Grossmann, Kai ^a   Knütter, Ilka ^a   Hiemann, Rico ^b   Sowa, Mandy ^a   Röber, Nadja ^c   Rödiger, Stefan ^b   Schierack, Peter ^b   Reinhold, Dirk ^d   Bogdanos, Dimitrios P ^e   Meroni, Pier Luigi ^f   Radice, Antonella ^g   Conrad, Karsten ^c   Roggenbuck, Dirk ^a,b  

^a GA GENERIC ASSAYS GMBH   (Germany)

^b BRANDENBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY OF THESSALY   (Greece)

^f UNIVERSITY OF MILAN   (Italy)

^g SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

antinuclear antibody; digital fluorescence; second generation ANA testing; standardization; systemic autoimmune rheumatic disease

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE PROTEIN B; DOUBLE STRANDED DNA ANTIBODY; LA ANTIBODY; RO ANTIBODY; SCL 70 ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE LIVER DISEASE; BLOOD DONOR; CLINICAL ASSESSMENT; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS INFECTION; FEMALE; HEP 2 CELL LINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOFLUORESCENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; MYOSITIS; PARAPROTEINEMIA; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROLOGY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ULCERATIVE COLITIS; VERY ELDERLY; AUTOIMMUNE DISEASES; BLOOD; HEPG2 CELL LINE; IMMUNOLOGY; INDIRECT FLUORESCENT ANTIBODY TECHNIQUE; RHEUMATIC DISEASES;

ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEP G2 CELLS; HUMANS; IMMUNOASSAY; RHEUMATIC DISEASES;

EID: 84946882239     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-0083     Document Type: Article

References (48)

1. Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as antinuclear antibodies. Ann Rheum Dis 2014;73:17-23.
2. Bossuyt X, Luyckx A. Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples. Clin Chem 2005;51:2426-7.
3. Mahler M, Meroni PL, Bossuyt X, Fritzler MJ. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014;2014:315179.
4. Pisetsky DS. Antinuclear antibodies in healthy people: The tip of autoimmunity's iceberg? Arthritis Res Ther 2011;13:109.
5. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
6. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
7. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69:1420-2.
8. Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002;47:434-44.
9. Van den Bergh K, Hooijkaas H, Blockmans D, Westhovens R, Op de Beeck K, Verschueren P, et al. Heterogeneous nuclear ribonucleoprotein h1, a novel nuclear autoantigen. Clin Chem 2009;55:946-54.
10. Eriksson C, Kokkonen H, Johansson M, Hallmans G, Wadell G, Rantapaa-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther 2011;13:R30.
11. Yukawa N, Fujii T, Kondo-Ishikawa S, Yoshifuji H, Kawabata D, Nojima T, et al. Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: A retrospective clinical study. Arthritis Res Ther 2011;13:R213.
12. Conrad K, Roggenbuck D, Reinhold D, Sack U. Autoantibody diagnostics in clinical practice. Autoimmun Rev 2012;11:207-11.
13. Willitzki A, Hiemann R, Peters V, Sack U, Schierack P, Rödiger S, et al. New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clin Dev Immunol 2012;2012:284740.
14. Hiemann R, Hilger N, Michel J, Nitschke J, Böhm A, Anderer U, et al. Automatic analysis of immunofluorescence patterns of HEp-2 cells. Ann NY Acad Sci 2007;1109:358-71.
15. Bossuyt X. Evaluation of two automated enzyme immunoassays for detection of antinuclear antibodies. Clin Chem Lab Med 2000;38:1033-7.
16. Damoiseaux J, Agmon-Levin N, Van BM, Chopyak V, Eriksson C, Heijnen I, et al. From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries. Clin Exp Rheumatol 2014;32:539-46.
17. Bossuyt X, Marien G, Vanderschueren S. A 67-year-old woman with a systemic inflammatory syndrome and sicca. Clin Chem 2010;56:1508-9.
18. Hiemann R, Büttner T, Krieger T, Roggenbuck D, Sack U, Conrad K. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 2009;9:17-22.
19. Roggenbuck D, Hiemann R, Bogdanos D, Reinhold D, Conrad K. Standardization of automated interpretation of immunofluorescence tests. Clin Chim Acta 2013;421C:168-9.
20. Roggenbuck D, Hiemann R, Schierack P, Reinhold D, Conrad K. Digital immunofluorescence enables automated detection of antinuclear antibody endpoint titers avoiding serial dilution. Clin Chem Lab Med 2014;52:e9-11.
21. Grossmann K, Roggenbuck D, Schröder C, Conrad K, Schierack P, Sack U. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay. Cytometry A 2011;79:118-25.
22. Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? J Rheumatol 2005;32:213-5.
23. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747-55.
24. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8.
25. Egerer K, Roggenbuck D, Hiemann R, Weyer MG, Büttner T, Radau B, et al. Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther 2010;12:R40.
26. Knütter I, Hiemann R, Brumma T, Büttner T, Grossmann K, Cusini M, et al. Automated interpretation of ANCA patterns-A new approach in the serology of ANCA-associated vasculitis. Arthritis Res Ther 2012;14:R271.
27. Hiemann R, Hilger N, Sack U, Weigert M. Objective quality evaluation of fluorescence images to optimize automatic image acquisition. Cytometry A 2006;69:182-4.
28. Holborow EJ, Weir DM, Johnson G. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J 1957;2:732-4.
29. Friou GJ, Finch SC, Detre KD. Interaction of nuclei and globulin from lupus erythematosis serum demonstrated with fluorescent antibody. J Immunol 1958;80:324-9.
30. Bonaguri C, Melegari A, Ballabio A, Parmeggiani M, Russo A, Battistelli L, et al. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results. Autoimmun Rev 2011;11:1-5.
31. Van Blerk M, Van Campenhout C, Bossuyt X, Duchateau J, Humbel R, Servais G, et al. Current practices in antinuclear antibody testing: results from the Belgian External Quality Assessment Scheme. Clin Chem Lab Med 2009;47:102-8.
32. Mierau R, Moinzadeh P, Riemekasten G, Melchers I, Meurer M, Reichenberger F, et al. Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features. Arthritis Res Ther 2011;13:R172.
33. Op de Beeck K, Vermeersch P, Verschueren P, Westhovens R, Marien G, Blockmans D, et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011;10:801-8.
34. Shovman O, Gilburd B, Barzilai O, Shinar E, Larida B, Zandman-Goddard G, et al. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann NY Acad Sci 2005;1050:380-8.
35. Op de Beeck K, Vermeersch P, Verschueren P, Westhovens R, Marien G, Blockmans D, et al. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev 2012;12:137-43.
36. Kroshinsky D, Stone JH, Bloch DB, Sepehr A. Case records of the Massachusetts General Hospital. Case 5-2009. A 47-year-old woman with a rash and numbness and pain in the legs. N Engl J Med 2009;360:711-20.
37. Meroni PL, Bizzaro N, Cavazzana I, Borghi MO, Tincani A. Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations. BMC Med 2014;12:38.
38. Rödiger S, Schierack P, Böhm A, Nitschke J, Berger I, Frömmel U, et al. A highly versatile microscope imaging technology platform for the multiplex real-time detection of biomolecules and autoimmune antibodies. Adv Biochem Eng Biotechnol 2013;133:35-74.
39. Buzzulini F, Rigon A, Soda P, Onofri L, Infantino M, Arcarese L, et al. The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system. Arthritis Res Ther 2014;16:R71.
40. Bizzaro N, Antico A, Platzgummer S, Tonutti E, Bassetti D, Pesente F, et al. Automated antinuclear immunofluorescence antibody screening: A comparative study of six computer-aided diagnostic systems. Autoimmun Rev 2014;13:292-8.
41. Kivity S, Gilburd B, Agmon-Levin N, Carrasco MG, Tzafrir Y, Sofer Y, et al. A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol 2011;31:503-9.
42. Melegari A, Bonaguri C, Russo A, Luisita B, Trenti T, Lippi G. A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev 2012;11:713-6.
43. Bonroy C, Verfaillie C, Smith V, Persijn L, De Witte E, De Keyser F, et al. Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation. Clin Chem Lab Med 2013;51:1771-9.
44. Bossuyt X, Cooreman S, De Baere H, Verschueren P, Westhovens R, Blockmans D, et al. Detection of antinuclear antibodies by automated indirect immunofluorescence analysis. Clin Chim Acta 2013;415:101-6.
45. Roggenbuck D, Reinhold D, Hiemann R, Anderer U, Conrad K. Standardized detection of anti-ds DNA antibodies by indirect immunofluorescence-A new age for confirmatory tests in SLE diagnostics. Clin Chim Acta 2011;412:2011-2.
46. Sowa M, Grossmann K, Knütter I, Hiemann R, Röber N, Anderer U, et al. Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA. PLoS One 2014;9:e107743.
47. Sowa M, Großmann K, Scholz J, Röber N, Rödiger S, Schierack P, et al. The CytoBead assay-A novel approach multiparametric autoantibody analysis in the diagnostics of systemic autoimmune diseases. J Lab Med 2014;38:309-17.
48. Roggenbuck D, Conrad K, Reinhold D. High sensitive detection of double-stranded DNA antibodies by a modified Crithidia luciliae immunofluorescence test may improve diagnosis of systemic lupus erythematosus. Clin Chim Acta 2010;411:1837-8.